Dr. Vasilis Babaliaros, MD
Claim this profileEmory University Hospital
Studies Tricuspid Regurgitation
Studies Cardiovascular Disease
7 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Vasilis Babaliaros, MD is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Tendyne Transcatheter Mitral Valve System
for Mitral Regurgitation
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria
More about Vasilis Babaliaros, MD
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Vasilis Babaliaros, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- SAPIEN 3/SAPIEN 3 Ultra RESILIA THV
- Abbott Mitraclip System
- SAPIEN 3 THV
- MitraClip System
Breakdown of trials Vasilis Babaliaros, MD has run
Tricuspid Regurgitation
Cardiovascular Disease
Valvular Heart Disease
Heart Valve Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vasilis Babaliaros, MD specialize in?
Vasilis Babaliaros, MD focuses on Tricuspid Regurgitation and Cardiovascular Disease. In particular, much of their work with Tricuspid Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Vasilis Babaliaros, MD currently recruiting for clinical trials?
Yes, Vasilis Babaliaros, MD is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Vasilis Babaliaros, MD has studied deeply?
Yes, Vasilis Babaliaros, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, SAPIEN 3/SAPIEN 3 Ultra RESILIA THV.
What is the best way to schedule an appointment with Vasilis Babaliaros, MD?
Apply for one of the trials that Vasilis Babaliaros, MD is conducting.
What is the office address of Vasilis Babaliaros, MD?
The office of Vasilis Babaliaros, MD is located at: Emory University Hospital, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.